A new drug used to help prevent migraines in adults was just approved by the United States Food and Drug Administration, WAFB reports. The new drug is called Emgality and is used specifically to prevent migraines, not to treat the pain caused by them.
The list price for the drug is $575 per month. That price point is expensive but could be worth it for Americans who are suffering from consistent, debilitating migraines. Severe migraines can cause pain in the head, vomiting, nausea, and sensitivity to light. People suffering from migraines typically need to take time off work or are unable to perform daily functions as normal while they are afflicted.
#FDAapproves new drug for the preventive treatment of migraine in adults: https://t.co/SPZk775P0D. pic.twitter.com/bij3UrcVY1
— FDA Drug Information (@FDA_Drug_Info) September 28, 2018
0 comments :
Post a Comment